Animal Models of Drug Addiction

George F. Koob
Department of Neuropharmacology
The Scripps Research Institute
La Jolla, California 92037.


1. Baldwin HA, Koob GF. Rapid induction of conditioned opiate withdrawal. Neuropsychopharmacology 1993;8:15–21.

2. Bergman J, Kamien JB, Spealman RD. Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonist. Behav Pharmacol 1990;1:355–363.

3. Bertalmio AJ, Herling S, Hampton RY, Winger G, Woods JH. A procedure for rapid evaluation of the discriminative stimulus effects of drugs. J Pharmacol Exp Ther 1982;141:289–299.

4. Brady JV. Emotion revisited. J Psychiatr Res 1971;8:363–384.

5. Caine SB, Koob GF. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 1993;260:1814–1816.

6. Caine SB, Lintz R, Koob GF. Intravenous drug self-administration techniques in animals. In: Sahgal A, ed. Behavioral neuroscience: a practical approach. New York: Oxford University Press; 1993:93–115.

7. Carr GD, Fibiger HC, Phillips AG. Conditioned place preference as a measure of drug reward. In: Liebman JM, Cooper SJ, eds. The neuropharmacological basis of reward. New York: Oxford University Press; 1989:264–319.

8. Carroll ME, Lac TL, Nygaard SL. A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior. Psychopharmacology 1989;97:23–29.

9. Childress AR, McLellan AT, Ehrman R, O'Brien CP. Classically conditioned responses in opioid and cocaine dependence: a role in relapse? NIDA Research Monograph 84. Rockville, MD: Department of Health and Human Services; 1988:25–43.

10. Collins RJ, Weeks JR, Cooper MM, Good PI, Russell RR. Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology 1984;82:6–13.

11. Colpaert FC, Lal H, Niemegeers CJE, Janssen PAJ. Investigations on drug produced and subjectively experienced discriminative stimuli. 1. The fentanyl cue, a tool to investigate subjectively experienced narcotic actions. Life Sci 1975;16:705–716.

12. Davis WM, Smith SG. Role of conditioned reinforcer in the initiation, maintenance and extinction of drug-seeking behavior. Pavlov J Biol Sci 1976;11:222–236.

13. Denoble U, Begleiter H. Response suppression on a mixed schedule of reinforcement during alcohol withdrawal. Pharmacol Biochem Behav 1976;5:227–229.

14. Ehrman RN, Robbins SJ, Childress AR, O'Brien CP. Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology 1992;107:523–529.

15. Elsmore TF, Fletcher GV, Conrad DG, Sodetz FJ. Reduction of heroin intake in baboons by an economic constraints. Pharmacol Biochem Behav 1980;13:729–731.

16. Emmett-Oglesby MW, Mathis DA, Moon RTY, Lal H. Animal models of drug withdrawal symptoms. Psychopharmacology 1990;101:292–309.

17. Fischman MW. Relationship between self-reported drug effects and their reinforcing effects: studies with stimulant drugs. In: Fischman MW, Mello NK, eds. Testing for abuse liability of drugs in humans. NIDA Research Monograph 92. Rockville, MD: Department of Health and Human Services; 1989:211–230.

18. France CP, Woods JH. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys. J Pharmacol Exp Ther 1989;250:937–943.

19. Gallistel CR. Self-stimulation. In: Deutsch JA, ed. The physiological basis of memory. New York: Academic Press; 1983:73–77.

20. Gauvin DV, Holloway FA. Cue dimensionality in the 3-choice pentylenetetrazole-saline-chlordiazepoxide discrimination task. Behav Pharmacol 1991;2:417–428.

21. Gellert VF, Holtzman SG. Discriminative stimulus effects of naltrexone in the morphine-dependent rat. J Pharmacol Exp Ther 1979;211:596–605.

22. Gellert VF, Sparber SB. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats. J Pharmacol Exp Ther 1977;201:44–54.

23. Gerber GJ, Stretch R. Drug-induced reinstatement of extinguished self-administration behavior in monkeys. Pharmacol Biochem Behav 1975;3:1055–1061.

24. Goldberg SR. Stimuli associated with drug injections as events that control behavior. Pharmacol Rev 1976;27:325–340.

25. Goldberg SR, Gardner ML. Second-order schedules: extended sequences of behavior controlled by brief environmental stimuli associated with dosing administration. In: Thompson T, Johanson CE, eds. Behavioral pharmacology of human drug dependence. NIDA Research Monograph No. 37, DHEW Publication No. (ADM) 81-1137, Washington, DC: U.S. Government Printing Office; 1981:241–270.

26. Goldberg SR, Hoffmeister F, Schlichting V, Wolfgang W. Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys. J Pharmacol Exp Ther 1971;179:268–276.

27. Goldberg SR, Schuster CR. Suppression by a stimulus associated with nalorphine in morphine-dependent monkeys. J Exp Anal Behav 1967;10:235–242.

28. Goldberg SR, Schuster CR. Conditioned nalorphine-induced abstinence changes: persistence in post morphine-dependent monkeys. J Exp Anal Behav 1970;14:33–46.

29. Goldberg SR, Woods JH, Schuster CR. Morphine: conditioned increases in self-administration in rhesus monkeys. Science 1969;166:1306–1307.

30. Griffiths RR, Brady JV, Snell JD. Progressive ratio performance maintained by drug infusions: comparison of cocaine, diethylpropion, chlorphentermine, and fenfluramine. Psychopharmacology 1978;56:5–13.

31. Hand TH, Koob GF, Stinus L, Le Moal M. Aversive properties of opiate receptor blockade are centrally mediated and are potentiated by previous exposure to opiates. Brain Res 1988;474:364–368.

32. Holtzman SG. Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Modern methods in pharmacology. Vol. 6. Testing and evaluation of drugs of abuse. New York: Wiley-Liss; 1990:193–210.

33. Holtzman SG, Villarreal JE. Operant behavior in the morphine-dependent rhesus monkey. J Pharmacol Exp Ther 1973;184(3): 528–541.

34. Johanson CE. Pharmacological and environmental variables affecting drug preference in rhesus monkeys. Pharmacol Rev 1976;27:343–355.

35. Johanson CE, Balster RL. A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Bull Narc 1978;30:43–54.

36. Katz JL, Goldberg SR. Second-order schedules of drug injection: implications for understanding reinforcing effects of abused drugs. In: Mello NK, ed. Advances in substance abuse. vol. 4. London: Jessica Kingsley Publishers; 1991:205–223.

37. Kelleher RT. Characteristics of behavior controlled by scheduled injections of drugs. Pharmacol Rev 1975;27:307–323.

38. Kelley AE, Delfs JM. Amphetamine and conditioned reinforcement. II. Contrasting effects of amphetamine microinjection into the nucleus accumbens with peptide microinjection into the ventral tegmental area. Psychopharmacology 1991;103:197–203.

39. Kokkinidis L, McCarter BD. Postcocaine depression and sensitization of brain stimulation reward: analysis of reinforcement and performance effects. Pharmacol Biochem Behav 1990;36:463–471.

40. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science 1988;242:715–723.

41. Koob GF, Goeders N. Neuroanatomical substrates of drug self-administration. In: Liebman JM, Cooper SJ, eds. Neuropharmacological basis of reward, Vol. 6. New York: Oxford University; 1989:214–264.

42. Koob GF, Markou A, Weiss F, Schulteis G. Opponent process and drug dependence: Neurobiological mechanisms. Semin Neurosci 1993;5:351–358.

43. Kornetsky C, Esposito RU. Euphorigenic drugs: effects on reward pathways of the brain. Fed Proc 1979;38:2473–2476.

44. Lamb RJ, Preston KL, Schindler CW, et al. The reinforcing and subjective effects of morphine in post-addicts: a dose–response study. J Pharmacol Exp Ther 1991;259:1165–1173.

45. Leith NJ, Barrett RJ. Amphetamine and the reward system: evidence for tolerance and post-drug depression. Psychopharmacologia 1976;46:19–25.

46. Markou A, Koob GF. Post cocaine anhedonia. An animal model of cocaine withdrawal. Neuropharmacology 1991;4:17–26.

47. Markou A, Koob GF. Intracranial self-stimulation thresholds as a measure of reward. In: Sahgal A, ed. Behavioral neuroscience: a practical approach. New York: Oxford University Press; 1993:93–115.

48. Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF. Animal models of drug craving. Psychopharmacology 1993;112: 163–182.

49. McDonald RJ, White NM. A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum. Behav Neurosci 1993;107(1):3–22.

50. Milliaressis E, Rompre PP, Laviolette P, Philippe L, Coulombe D. The wave-shift paradigm in self-stimulation. Physiol Behav 1986;37:85–91.

51. O'Brien CP, Jesta J, O'Brien TJ, Brady JP, Wells B. Conditioned narcotic withdrawal in humans. Science 1977;195:1000–1002.

52. Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 1954;47:419–427.

53. Overton DA. Experimental methods for the study of state-dependent learning. Fed Proc 1974;33:1800–1813.

54. Piazza PV, Deminiere J-M, LeMoal M, Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989;245:1511–1513.

55. Robbins TW. The potentiation of conditioned reinforcement by psychomotor stimulant drugs: a test of Hill's hypothesis. Psychopharmacologia 1975;45:103–114.

56. Roberts DCS, Loh EA, Vickers G. Self-administration of cocaine on a progressive ratio schedule in rats: dose–response relationship and effect of haloperidol pretreatment. Psychopharmacology 1989;97:535–538.

57. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993;18:247–291.

58. Schulteis G, Carrera R, Markou A, Gold LH, Koob GF. Motivational consequences of naloxone-precipitated opiate withdrawal: a dose-response analysis. Neurosci Abstr 1993;19:1247.

59. Schuster CR, Johanson CE. Relationship between the discriminative stimulus properties and subjective effects of drugs. In: Colpaert FC, Balster RL, eds. Transduction mechanisms of drug stimuli. Berlin: Springer-Verlag, 1988;161.

60. Schuster CR, Thompson T. Self-administration and behavioral dependence on drugs. Annu Rev Pharmacol Toxicol 1969;9:483–502.

61. Schuster CR, Woods JH. The conditioned reinforcing effects of stimuli associated with morphine reinforcement. Int J Addict 1968;3:223–230.

62. Shannon HE. Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats. J Pharmacol Exp Ther 1982;222(1):146–151.

63. Stellar JR, Stellar E. The neurobiology of reward and motivation, New York: Springer-Verlag, 1985.

64. Stewart J, deWit H. Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs. In: Bozarth MA, ed. Assessing the reinforcing properties of abused drugs. New York: Springer-Verlag; 1987:211–227.

65. Stewart J, Eikelboom R. Conditioned drug effects. In: Iversen LI, Iversen SD, Snyder SH, eds. New directions in behavioral pharmacology. Vol 19. New York: Plenum Press; 1987:1–57.

66. Stinus L, Le Moal M, Koob GF. The nucleus accumbens and amygdala as possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 1990;37:767–773.

67. Stolerman IP, Rasul F, Shine PJ. Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984–1987. Psychopharmacology 1989;73:1–19.

68. Swerdlow NR, Gilbert D, Koob GF. Conditioned drug effects on spatial preference. In: Boulton AB, Baker GB, Greenshaw AJ, eds. Neuromethods. Vol 13. Clifton, NJ: The Humana Press, 1989;399–446.

69. van der Kooy D. Place conditioning: a simple and effective method for assessing the motivational properties of drugs. In: Bozarth MA, ed. Methods of assessing the reinforcing properties of abused drugs. New York: Springer-Verlag; 1987:229–240.

70. Wikler A. Dynamics of drug dependence: implications of a conditioning theory of research and treatment. Arch Gen Psychiatry 1973;28:611–616.

71. Wikler A, Pescor FT. Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and "relapse" in morphine addicted rats. Psychopharmacologia 1967;10:255–284.

72. Wikler A, Pescor FT, Miller D, Norrell H. Persistent potency of a secondary (conditioned) reinforcer following withdrawal of morphine from physically dependent rats. Psychopharmacology 1971;20:103–117.

73. Winger G, Woods JH. Comparison of fixed-ratio and progressive-ratio schedules of maintenance of stimulant drug-reinforced responding. Drug Alcohol Depend 1985;15:123–130.

74. Wise R. The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 1988;97:118–132.

75. Yanagita T. An experimental framework for evaluations of dependence liability of various types of drugs in monkeys. Bull Narc 1973;25:57–64.

Back to Chapter

published 2000